Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
China flag China · Delayed Price · Currency is CNY
27.85
+0.24 (0.87%)
Apr 29, 2026, 3:04 PM CST

SHE:300204 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21 2020 - 2016
Market Capitalization
13,30613,0533,5404,8546,4198,242
Upgrade
Market Cap Growth
288.42%268.69%-27.07%-24.38%-22.12%94.35%
Upgrade
Enterprise Value
13,28312,9263,4984,7116,1137,806
Upgrade
Last Close Price
27.8527.327.4110.1613.6017.55
Upgrade
Forward PE
-78.5078.5078.5078.5078.50
Upgrade
PS Ratio
65.2559.2710.9013.3311.6914.11
Upgrade
PB Ratio
16.7416.183.864.764.745.32
Upgrade
P/TBV Ratio
17.6517.074.055.035.125.70
Upgrade
EV/Sales Ratio
65.1458.6910.7712.9411.1413.36
Upgrade
Debt / Equity Ratio
0.150.100.050.040.020.01
Upgrade
Net Debt / Equity Ratio
-0.01-0.05-0.01-0.04-0.17-0.30
Upgrade
Net Debt / EBITDA Ratio
0.150.780.510.131.172.23
Upgrade
Net Debt / FCF Ratio
0.040.210.130.171.022.10
Upgrade
Asset Turnover
0.170.180.260.240.310.32
Upgrade
Inventory Turnover
2.022.422.893.754.643.69
Upgrade
Quick Ratio
1.340.950.610.711.963.18
Upgrade
Current Ratio
2.001.441.151.152.283.50
Upgrade
Return on Equity (ROE)
-10.70%-10.22%-15.25%-33.60%-13.56%-8.76%
Upgrade
Return on Assets (ROA)
-4.09%-4.06%-2.24%-15.56%-8.36%-8.13%
Upgrade
Return on Invested Capital (ROIC)
-10.32%-9.39%-4.73%-35.68%-21.17%-23.89%
Upgrade
Return on Capital Employed (ROCE)
-7.00%-7.20%-4.50%-33.20%-16.30%-14.70%
Upgrade
Earnings Yield
-0.63%-0.60%-4.09%-8.22%-3.07%-1.67%
Upgrade
FCF Yield
-1.64%-1.55%-2.46%-5.37%-3.62%-2.65%
Upgrade
Buyback Yield / Dilution
11.76%-0.66%-1.67%1.17%-1.42%0.27%
Upgrade
Total Shareholder Return
11.76%-0.66%-1.67%1.17%-1.42%0.27%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.